Advertisement
Screener

Nugenerex Immuno-oncology, Inc. Earnings Per Share, Basic and Diluted

Nugenerex Immuno-oncology, Inc. Earnings Per Share, Basic and Diluted

Nugenerex Immuno-oncology, Inc. reported Earnings Per Share, Basic and Diluted of -$0.02 per share for the 3-month period ending 2021-04-30, per its 10-Q filed 2021-06-14.

Discontinued › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-06-14

  • Nugenerex Immuno-oncology, Inc. earnings per share, basic and diluted for the quarter ending 2021-04-30 was -$0.02.
  • Nugenerex Immuno-oncology, Inc. earnings per share, basic and diluted for the quarter ending 2021-01-31 was -$0.01.
  • Nugenerex Immuno-oncology, Inc. earnings per share, basic and diluted for the quarter ending 2020-10-31 was $0.00.
  • Nugenerex Immuno-oncology, Inc. earnings per share, basic and diluted for the quarter ending 2020-04-30 was $0.00.
  • Nugenerex Immuno-oncology, Inc. earnings per share, basic and diluted for fiscal 2020 was $0.00.
  • Nugenerex Immuno-oncology, Inc. earnings per share, basic and diluted for fiscal 2019 was $0.00.
Period endEarnings Per Share, Basic and Diluted 3 monthEarnings Per Share, Basic and Diluted 6 monthEarnings Per Share, Basic and Diluted 9 monthEarnings Per Share, Basic and Diluted 12 month
2021-04-30-$0.02
10-Q · filed 2021-06-14
-$0.02
derived: net income ÷ weighted average shares · filed 2021-06-14
-$0.02
10-Q · filed 2021-06-14
2021-01-31-$0.01
10-Q · filed 2021-03-12
-$0.01
10-Q · filed 2021-03-12
2020-10-31$0.00
10-Q · filed 2020-12-15
2020-07-31$0.00
10-K · filed 2020-10-29
2020-04-30$0.00
10-Q · filed 2021-06-14
-$0.00
derived: net income ÷ weighted average shares · filed 2021-06-14
$0.00
10-Q · filed 2021-06-14
2020-01-31$0.00
10-Q · filed 2021-03-12
$0.00
10-Q · filed 2021-03-12
2019-10-31$0.00
10-Q · filed 2020-12-15
2019-07-31$0.00
10-K · filed 2020-10-29
2019-04-30$0.00
10-Q · filed 2020-06-19
$0.00
10-Q · filed 2020-06-19
2019-01-31$0.00
10-Q · filed 2020-06-17
$0.00
10-Q · filed 2020-06-17